Effectiveness of continuous wound infusion of local anesthetic versus intravenous administration of fentanyl citrate after gynecologic surgery, randomized controlled trial

Effectiveness of continuous wound infusion of local anesthetic versus intravenous administration of fentanyl citrate after gynecologic surgery, randomized controlled trial - Effectiveness of continuous wound infusion of local anesthetics versus intravenous administration of fentanyl citrate after gynecologic surgery, randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000033979

Enrollment

Registered

2018-09-03

Start date

2018-08-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecologic disease

Interventions

interventions/ placement porous catheter infrafascia,and administer 0.25 % ropivacaine continuously during 48 hour control/ administer fentanyl citrate 20 ug/hour transvenously during 48 hour

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: patients planned for elective midline laparotomy for gynecologic surgery

Exclusion criteria

Exclusion criteria: 1)can not use IV-PCA 2)history of postoperative pain management difficulty 3)emergency surgery 4)psychiatric disease 5)use opiate or NSAIDs routinely 6)ropivacaine or NSAIDs allergy 7)BMI>35kg/m2 8)systematic infection

Design outcomes

Primary

Measure	Time frame
Visual analogue scale on 24 hour after surgery	—

Secondary

Measure	Time frame
frequency of adjuvant analgesics, time until require adjuvant analgesics after surgery, amount of consumption of fentanyl citrate, visual analogue scale on 48 hour after surgery, number of days until ambulation, frequency of vomiting or nausea, presence of vertigo or dizziness, frequency of local anesthetic intoxication, frequency of wound infection, other adverse events	—

Countries

Japan

Contacts

Public ContactHirotaka Nakamura

tokyo metropolitan tama medical center Obstetrics and Gynecology

nakamurahirotaka0114@yahoo.co.jp042-323-5111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026